DE NOVO ATYPICAL HEMOLYTIC UREMIC SYNDROME (aHUS) IN A RENAL TRANSPLANT RECIPIENT
ISN Academy, Efren Chavez Morales, 178291
OUTCOME AND COMPLICATIONS OF TEMPORARY HEMODIALYSIS CATHETERS: A PROSPECTIVE STUDY FROM A SINGLE CENTER IN MOROCCO
ISN Academy, HICHAM RAFIK, 178328
UNDERSTANDING FACTORS IMPEDING AND FACILITATING TIMELY INITIATION OF DIALYSIS
ISN Academy, terina seow, 178330
ROLE OF BIOMARKERS IN CONTRAST-INDUCED ACUTE KIDNEY INJURY IN CRITICALLY ILL PATIENTS
ISN Academy, Mohan Gurjar, 178335
BIOMARKERS AS AKI ARE NOT ALIKE. TEMP1 IS UNIVERSAL, NGAL MAY BE SEPTIC, PROCALCITONIN MAY NOT, TEMP2 IS LATE. HOWEVER; ALL DEPEND ON THE CAUSE?
ISN Academy, Ahmed Adam, 178338
EPIDEMIOLOGY, CLINICAL CHARACTERISTICS, OUTCOME OF ACUTE KIDNEY INJURY AND ITS PREDICTIVE BIOMARKERS IN INTENSIVE CARE UNITS OF ALEXANDRIA UNIVERSITY HOSPITALS
ISN Academy, Ahmed Adam, 178339
AKI CELL CYCLE ARREST BIOMARKERS AND FLUID BALANCE AS PREDICTORS OF SURVIVAL IN PATIENTS WITH RISK OF DEVELOPING ACUTE KIDNEY INJURY IN ICU.
ISN Academy, Lilia Rizo Topete, 178341
EVALUATION OF PATIENT AND KIDNEY SURVIVAL IN PATIENTS WITH IGA NEPHROPATHY AND ITS RELATIONSHIP WITH OXFORD CLASSIFICATION (MEST)
ISN Academy, Shahrzad Ossareh, 178379
THE RELATIONSHIP BETWEEN CLINICOPATHOLOGIC FINDINGS AND OUTCOME OF MORPHOLOGIC VARIANTS OF PRIMARY FOCAL SEGMENTAL GLOMERULOSCLEROSIS
ISN Academy, Shahrzad Ossareh, 178380
PREVALENCE OF MACROALBUMINURIA AND ASSOCIATED RISK FACTORS AMONG DIABETIC PATIENTS IN MOSHI NORTHERN TANZANIA.
ISN Academy, Kajiru Kilonzo, 178386
RED CELL DISTRIBUTION WIDTH PREDICTS CHRONIC KIDNEY DISEASE IN ELDERLY UNCONTROLLED TYPE 2 DIABETIC PATIENTS
ISN Academy, Sahier El Khashab, 178396
TIME TREND OF IDEAL BIOMARKER OF ACUTE KIDNEY INJURY IN DIABETIC PATIENTS UNDERGOING CORONARY ARTERY BYPASS GRAFT (CABG)
ISN Academy, Ahmed Adam, 178397
Validation of point of care device for urine microalbumin/creatinine, serum albumin and HbA1c: correlations and applications in diabetic kidney disease
ISN Academy, Urmila Anandh, 178402
SUBCLINICAL ARTERIOPATHY IS COMMON IN EARLY STAGES OF CHRONIC KIDNEY DISEASE AMONG CHILDREN AND ADOLESCENTS
ISN Academy, Lourdes Paula R. Resontoc, 178436
Adipose-derived mesenchymal stem cells attenuate vascular calcification in rats with adenine-induced kidney disease.
ISN Academy, Shinya Yokote, 178441
ALPHA-2 HEREMANS-SCHMID GLYCOPROTEIN (AHSG) GENE POLYMORPHISM IN CHILDREN WITH CHRONIC KIDNEY DISEASE
ISN Academy, Abdullahi Mudi, 178442
Cardio-metabolic risks factors in children with secondary glomerulopathies.
ISN Academy, Mohsen Hoshyarikhani, 178443
THE INFLUENCE OF INFLAMMATORY GENETIC MARKERS AND SERUM INFLAMMATORY CYTOKINE LEVELS ON ATHEROSCLEROSIS RISK IN SOUTH AFRICAN CHRONIC KIDNEY DISEASE PATIENTS
ISN Academy, Muzamil Hassan, 178444
TOLL-LIKE RECEPTOR-4 ASP299GLY POLYMORPHISM PROTECTS AGAINST ATHEROSCLEROSIS IN BLACK SOUTH AFRICAN CHRONIC KIDNEY DISEASE PATIENTS
ISN Academy, Muzamil Hassan, 178445
APOL1 GENETIC VARIANTS CONTRIBUTE TO ATHEROSCLEROTIC CARDIOVASCULAR DISEASE RISK IN BLACK SOUTH AFRICANS
ISN Academy, Muzamil Hassan, 178446
IMPACT OF PERITONEAL DIALYSATE WITH LOW CALCIUM CONCENTRATION ON INTACT PARATHYROID HORMONE
ISN Academy, G Ottati, 178462
FERRIC PYROPHOSPHATE CITRATE (TRIFERIC) DELIVERY VIA PERITONEAL DIALYSATE FOR IRON SUPPLEMTATION IN RATS
ISN Academy, Ajay Gupta, 178463
INFLUENCE OF THE INTRA AND EXTRA - PERITONEAL SEGMENT OF THE PERITONEAL CATHETER ON INFECTIOUS AND MECHANICAL COMPLICATIONS AND TECHNIQUE SURVIVAL
ISN Academy, Vanessa Banin, 178464
TRANSCRIPTIONAL MODULATION OF IL-17-STIMULATED CHEMOKINE CXCL1 PRODUCTION BY IFN-GAMMA IN HUMAN PERITONEAL MESOTHELIAL CELLS
ISN Academy, Achim Jörres, 178466
COMPARISON OF THE TENCKHOFF CATHETER, SPIRAL VERSUS RECTUM. CLINICAL TRIAL
ISN Academy, Juan Carlos Contreras Velázquez, 178468
COMPARISON OF THE PLACEMENT OF THE TENCKHOFF PERITONEAL CATHETER: SURGICAL VERSUS PERCUTANEOUS TECHNIQUE. CLINICAL TRIAL
ISN Academy, Juan Carlos Contreras Velázquez, 178470
EFFECT OF INDOXYL SULFATE ON THE BIOLOGICAL ACTIVITY OF HUMAN NEUTROPHILS
ISN Academy, Andrea MORENO-AMARAL, 178473
SODIUM GLUCOSE CO-TRANSPORTER 2 (SGLT2) INHIBITORS PREVENTING THE COMPLICATIONS OF DIABETES ACROSS THE SPECTRUM OF KIDNEY FUNCTION? THE CANAGLIFLOZIN TRIAL PROGRAM
ISN Academy, Dick de Zeeuw, 178498
CLINICAL AND HISTOLOGICAL FEATURES OF NON-DIABETIC KIDNEY DISEASE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS: RENAL RETINAL RELATIONSHIP
ISN Academy, Srikanth Prasad, 178504
KNOWLEDGE OF PRIMARY CARE PHYSICIANS ABOUT CHRONIC KIDNEY DISEASE AND CRITERIA FOR REFERRAL TO NEPHROLOGISTS IN PERU IN 2016
ISN Academy, Alaciel Melissa Palacios GuillÉn, 178507
Prevalence of Hypertension-attributed CKD (nephropathy) in patients with treated essential hypertension
ISN Academy, Bolanle Omotoso, 178508
MONTHLY DIRECT AND INDIRECT COST OF MANAGEMENT OF CKD3-5ND IN AN OUT-OF-POCKET EXPENDITURE SYSTEM. CASE OF YAOUNDE
ISN Academy, Francois Ngeugoue, 178510
DEVELOPMENT AND VALIDATION OF A CLINICAL COMPETENCE TEST FOR DIETITIANS REGARDING EARLY CHRONIC KIDNEY DISEASE (CKD)
ISN Academy, Roxana Michel Marquez, 178512
ASSESSMENT OF PATIENTS SATISFACTION TREATED IN A DIALYSIS CENTER
ISN Academy, Cesar Loza Munarriz, 178513
IDIOPATHIC MINIMAL-CHANGE DISEASE IN ADULTS: LONG-TERM EVOLUTION
ISN Academy, meriam meriam, 178536
LOWER URINARY EPIDERMAL GROWTH FACTOR LEVELS PREDICT STEEPER GFR DECLINE IN THE GENERAL NON-DIABETIC POPULATION
ISN Academy, Toralf Melsom, 178537
SERIAL ASSESSMENT OF KIDNEY VOLUME BY ULTRASONOGRAPHY AS A PREDICTOR OF PROGRESSION OF CHRONIC KIDNEY DISEASE
ISN Academy, Sujit Kumar, 178547
Epidemiology of hospitalized adult patients with acute kidney injury: A single-center retrospectively observational study
ISN Academy, Huijuan Mao, 178551
IMPAIRED RENAL FUNCTION IN PATIENTS WITH ACUTE DECOMPENSATED HEART FAILURE IN A TERTIARY HOSPITAL IN NIGERIA
ISN Academy, Manmak Mamven, 178552
COUNTRY CHARACTERISTICS ASSOCIATED WITH ACUTE KIDNEY INJURY (AKI) MORTALITY: RESULT FROM THE 0BY25 GLOBAL SNAPSHOT
ISN Academy, Raul Lombardi, 178557
ON-LINE COURSES ON ACUTE KIDNEY INJURY FOR LATIN AMERICA: A PIONEER EDUCATIONAL EXPERIENCE IN THE REGION.
ISN Academy, Raul Lombardi, 178558
URIC ACID AND RESIDUAL RENAL FUNCTION ON PERITONEAL DIALYSIS
ISN Academy, narjes narjes, 178575
INFLUENCE OF FLUID REMOVAL DURING HEMODIALYSIS ON HEMODYNAMIC PARAMETERS
ISN Academy, Nathan Levin, 178579
COMPARISON OF ENDOTHELIN - 1 LEVEL IN PATIENTS WITH INTRADIALYTIC HYPERTENSION AND NON INTRADIALYTIC HYPERTENSION PATIENTS IN CHRONIC KIDNEY DISEASE UNDERGOING HEMODIALYSIS IN RSMH PALEMBANG
ISN Academy, NOVADIAN HUSIN, 178580
IMPACT OF RESIDUAL RENAL FUNCTION IN NUTRITIONAL STATUS ON HEMDIALYSIS
ISN Academy, narjes narjes, 178582
TECHNICAL ASSISTANCE EFFORTS FOR DIALYSIS FACILITIES IN AND AROUND HANOI, VIETNAM
ISN Academy, tatsunori ogawa, 178584
EFFECT OF SODIUM DIALYSATE MODIFICATION ON BLOOD PRESSURE AND INTERDIALYTIC WEIGHT GAIN (IDWG) IN REGULAR HEMODIALYSIS PATIENTS
ISN Academy, Sjafrizal Nasution, 178587
VASCULAR ACCESS MORTALITY AND HOSPITALIZATION AMONG HEMODIALYSIS PATIENTS IN NORTHERN PALESTINE.
ISN Academy, Zakaria Hamdan, 178591
Kidney transplantation in Ghana is the public ready?
ISN Academy, Vincent Boima, 178617
RELIGION AS THE MAIN MOTIVATION TO DONATE A KIDNEY IN LIFE: REFLECTIONS FROM NORTHEAST BRAZIL
ISN Academy, Geraldo da Silva Junior, 178618
Update on the Renal Effects of Anti-Cancer Agents
ISN Academy, Mark A. Perazella, 178896
Assessment and Targets of Glycemic Control
ISN Academy, Ian De Boer, 178917
Medication Management for Hyperglycemia
ISN Academy, Alfonso Cueto Manzano, 178918
National Registries to Control CKD
ISN Academy, Laura Sola, 178947
Diabetic Kidney Disease versus Diabetes in People with CKD - What’s the Difference?
ISN Academy, Dick de Zeeuw, 205069
What Drives CKD Progression?
ISN Academy, Ariela Benigni, 178945
Lesson 1: Hereditary Tubulointerstitial Diseases
ISN Academy, Cynthia Nast, 178924
Lesson 2: Acute Tubular Injury - Morphologic Features Associated with Different Etiologies
ISN Academy, Mark Haas, 178926
Genetic Determinant of Drug Nephrotoxicity: Results from the Direct Study
ISN Academy, Linda Awdishu, 178897
Pathogenesis of Interstital Nephritis
ISN Academy, Allison Eddy, 178898
Herbal Medication Use and AKI
ISN Academy, Vivekanand Jha, 178899
USE OF ULINASTATIN IN RENAL FAILURE PATIENTS DEVELOPING SEPSIS
ISN Academy, Pavan Navva, 178900
PD or HD in People With Diabetes - What Are The Facts?
ISN Academy, Ricardo Correa Rotter, 178916
Bone Metabolism in Diabetics with CKD
ISN Academy, Ezequiel Bellorin-Font, 178920
Setting up a Clinical Trial
ISN Academy, David Wheeler, 178922
Conducting a Clinical Trial
ISN Academy, Chistoph Wanner, 178923
IgG4-Related Disease
ISN Academy, Lynn Cornell, 178925
IgA Nephropathy - An Enteric Disease?
ISN Academy, Renato C. Monteiro, 178927
Oxalate and Kidney Diseases
ISN Academy, Felix Knauf, 178928
0by25: A Vision Unfolding
ISN Academy, Giuseppe Remuzzi, 178940
AKI and the Global Burden of Disease
ISN Academy, Jorge Cerda, 178942
What Is Meaningful CKD Progression?
ISN Academy, Josef Coresh, 178944
Public Health Interventions for Delaying Kidney Disease Progression Globally
ISN Academy, Tazeen Jafar, 178946
Lifestyle and Medication Approaches
ISN Academy, Leigh Perreault, 178950
Novel Antiviral Strategies and Their Use in CKD
ISN Academy, Michel Jadoul, 178952
Eradicating HCV as a Cause Of CKD - Cryoglobulinemia Revisited
ISN Academy, Richard Johnson, 178953
Introduction of the ISN Bywaters Award. Presentation of the award to Raul Lombardi (Uruguay)
ISN Academy, Emmanuel Burdmann, 178966
Closing Remarks WCN 2017
ISN Academy, Adeera Levin, 178969
The Next Two Years
ISN Academy, David Harris, 178970
POTENTIAL PRESENCE OF CKD OF UNKNOWN ORIGIN (CKDu) IN THE UNITED STATES: AN ANALYSIS OF HOT SPOTS OF ESRD IN THE US
ISN Academy, Rajiv Saran, 177650
AVERAGE RATE OF DECLINE IN eGFR IS 8.8 mL/min/1.73m2 PER YEAR AMONGST APPARENTLY HEALTHY YOUNG ADULTS FROM COMMUNITIES AT RISK OF MESOAMERICAN NEPHROPATHY
ISN Academy, Marvin Antonio Gonzalez, 177651
CORRELATION OF EXPRESSION OF PLASMID-MEDIATED RESISTANCE GENES WITH ANTIBIOTIC RESISTANCE DEVELOPMENT IN UROPATHOGENS CLINICALLY ISOLATED FROM CHRONIC KIDNEY DISEASE PATIENTS WITH PYELONEPHRITIS
ISN Academy, Olga Chub, 177694
MANAGEMENT OF HEPATITIS C RELATED MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS IN THE ERA OF DIRECT ANTIVIRAL AGENTS
ISN Academy, Ali Shendi Mohamed, 177700
CKD4 PERIOD PATIENTS NUTRITION STATUS AND THE RALATIONSHIP BETWEEN THE INTESTINAL MUCOSAL IMMUNE BARRIER
ISN Academy, na hao, 177752
HEALTH INSURANCE AND PERITONEAL DIALYSIS USE IN THE UNITED STATES
ISN Academy, Samaya Qureshi, 177753
POST TRANSPLANT DIABETES MELLITUS (PTDM) IN KUWAIT
ISN Academy, Tarek Mahmoud, 177803
NON-DIABETIC RENAL DISEASE (NDRD) IN TYPE 2 DIABETES MELITUS: STUDY OF RENAL – RETINAL RELATIONSHIP
ISN Academy, Jai Prakash, 177804
MEDICAL STUDENTS IN THE WORLD KIDNEY DAY: KNOWLEDGE AND PREVENTION EXPERIENCE IN FORTALEZA CITY, BRAZIL
ISN Academy, Geraldo da Silva Junior, 177843
PREVENTING KIDNEY DISEASE: MEDICAL STUDENTS TAKING PART IN SOCIAL ACTS IN A LARGE URBAN AREA IN BRAZIL
ISN Academy, Geraldo da Silva Junior, 177844
FACILITATING VALUE-BASED RENAL CARE: THE CASE FOR CONVECTIVE THERAPIES
ISN Academy, Sudhir Bowry, 177876
AKI DEFINITION AND MANAGEMENT VARIABILITY, A NATIONAL SURVEY
ISN Academy, Mohamed Elrggal, 177884
IMPACT OF REGULAR OR EXTENDED HD AND HDF ON PLASMA OXALATE LEVELS IN ESRD PATIENTS
ISN Academy, Theresa Ermer, 177922
LUNG ULTRASOUND AS BED SIDE TEST FOR ASSESSMENT OF LUNG CONGESTION AND PREDICTION OF ISCHEMIC HEART DISEASE IN HEMODIALYSIS PATIENTS
ISN Academy, Sahier El Khashab, 177925
Metformin
ISN Academy, Marc De Broe, 178868
DPP-4 Inhibitors
ISN Academy, Per-Henrik Groop, 178869
Risk of Diabetes in Children with CKD: From Genetics to Environment
ISN Academy, Michel Tsimaratos, 178807
Diabetic Kidney Disease in the Pima Indians - Novelty or Harbinger?
ISN Academy, Robert Nelson, 178808
Introduction of the Roscoe R. Robinson Award. Presentation of the award to Mignon McCulloch (South Africa)
ISN Academy, John Feehally, 178834
MICRONUTRIENT LOSS IN RENAL REPLACEMENT THERAPY FOR ACUTE KIDNEY INJURY
ISN Academy, David Gardner, 178857
Designing a Randomised Clinical Trial
ISN Academy, Dick de Zeeuw, 178881

Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.


Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.



Google Analytics is used for user behavior tracking/reporting. Google Analytics works in parallel and independently from MLG’s features. Google Analytics relies on cookies and these cookies can be used by Google to track users across different platforms/services.


Save Settings